Top 8 AI News Updates Investors Shouldn’t Miss

3. Quest Diagnostics Inc. (NYSE:DGX)

Number of Hedge Fund Followers: 40

Quest Diagnostics Inc. (NYSE:DGX) leverages technology and innovation to offer diagnostic testing and information services. It uses large repositories of de-identifiable clinical lab results to help physicians gain accurate insights into diseases for better treatment and patient outcomes. The company has ramped up the deployment of AI in several areas of its organization, including microbiology and cytology testing, specimen processing, and customer service.

On March 18th, Quest Diagnostics (NYSE:DGX) announced a partnership with Google Cloud to optimize data management, enhance data analytics, improve patient engagement, and personalize experiences for providers. The company will utilize Google Cloud’s GenAI and data analytics technologies across segments, including R&D, operations, administrative workflows, and customer experience, while ensuring data privacy.

“We are excited about the potential to innovate and personalize the services we bring to our patients, clients, and employees. Google Cloud provides a best-in-class platform for securely streamlining and integrating data to generate novel insights and improve productivity. Google Cloud’s generative AI capabilities can help dismantle care roadblocks by personalizing the way patients and providers interact with us, improving care access, customer experiences, and quality.”

-said Murali Balakumar, SVP and chief information and digital officer at Quest Diagnostics Inc.